ANTIGEN FREQUENCY OF KELL, DUFFY, KIDD, MNS AND LUTHERAN BLOOD GROUP SYSTEM IN POPULATION OF NORTH MACEDONIA – TOWARDS RARE BLOOD GROUP REGISTRY
Keywords:
Blood group system, RBC antigen frequency, phenotypeAbstract
The aim of this study is to perform RBC antigen typing of: Kell, Duffy, Kidd, MNS and Lutheran systems and to calculate antigen and phenotype frequency
In 920 blood donors, RBC typing of K, k, Kpa, Kpb, Fya, Fyb, Jka, Jkb, S, s, Lua and Lub antigens was performed using specific monoclonal antisera, antihuman globulin and column agglutination technique with gel cards (BioRad). Antigen and phenotype frequencies were calculated from the statistics module of the donor information system (database for blood donors).
The prevalence of Kell antigens is 7.5% for K and 99.94% for k. The phenotype (K+k-) is present in 21 (0.06%) blood donors. The frequency of other clinically significant antigens is as follows: 1.1% (Kpa), 100.0% (Kpb), 60.3% (Jka), 76.2% (Jkb), 65.5% (Fya), 79.5% (Fyb), 59.8% (S), 86.5 (s), 7.2% (Lua) and 92.8% (Lub). The most frequent phenotypes are Jk(a+b+) with 41.5%, Fy(a+b+) with 48.5%, (S+ s+) with 46.3% and Lu(a-b+) with 92.8%. Fy(a-b-) phenotype was detected in 0.21% of blood donors.
The estimated RBC antigen frequency in our blood donor population differs from the antigen frequency in different populations. Because of that extended RBC typing is necessary for identifying rare blood group donors within the local population. This strategy enables to meet the needs for RBC transfusion in patients with rare phenotypes and with antibodies against high frequency antigens or multiple antibodies, as well as to prevent RBC alloimmunization in polytransfused patients providing antigen matched RBC.
References
ISBT Terminology Committee. Red cell immunogenetics and blood group terminology. Available from http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood.
Daniels G. The molecular genetics of blood group polymorphism. Transpl Immunol 2005; 14(3-4) 143-153. doi: 10.1016/j.trim.2005.03.003.
Cartron JP, Colin Y. Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001; 8(3): 163-99. doi: 10.1016/s1246-7820(01)00142-2.
Denomme GA. The structure and function of the molecules that carry human red blood cell and platelet antigens. Transf Med Rev 18(3): 203-31. doi: 10.1016/j.tmrv.2004.03. 006.
Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol 2004; 41(2): 93-117. doi: 10.1053/j.seminhematol.2004.01.001.
Daniels G, Bromilow I. Essential Guide to Blood Groups. 2nd Edition Wiley-Blackwel 2011.
Anstee DJ. The functional importance of blood group-active molecules in human red blood cells. Vox Sang 2011; 100(1): 140-149. doi: 10.1111/j.1423-0410.2010.01388.x.
Daniels G. Functions of red cell surface proteins. Vox Sang 2007; 93: 331-340. https://doi.org/ 10.1111/j.1423-0410.2007.00970.x.
Hemker MB, Cheroutre G, van Zwieten R, Maaskant-van Wijk PA, Roos D, Loos JA, et al. The Rh complex exports ammonium from human red blood cells. Br J Haematol 2003; 122(2): 333-340. https://doi.org/10.1046/j.1365-2141.2003.04425.x.
Proceeding of the International conference on the Rh protein superfamily. Transfus Clin Biol 2006; 13(1-2): 1-178.
Storry JR. Review: the function of blood group-specific RBC membrane components. Immunohaematology 2004; 20(4): 206-216. PMID: 15679452
Hadley TJ, PeIper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997; 89(9): 3077-3091. https://doi.org/ 10.1182/blood.V89.9.3077.
Eyler CE, Telen MJ. "The Lutheran glycoprotein: a multifunctional adhesion receptor". Transfusion 2006; 46(4): 668-677.
Zhang J, Abiraman K, Jones SM, Lykotrafitis G, Andemariam B. Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM. Biophys J 2017; 112(1): 143-152. doi: 10.1016/j.bpj.2016.11.3204.
Tanner MJA. Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 2002; 9(2): 133-139. doi: 10.1097/00062752-200203000-00009.
Bruce LJ, Beckmann R, Ribeiro ML, Peters LL, Chasis JA, Delaunay J, et al. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 2003; 101(10): 4180-4188. doi: 10.1182/blood-2002-09-2824.
Lee S, Russo D, Redman C. Functional and structural aspects of the Kell blood group system. Transfus Med Rev 2000; 14(2): 93-103. doi: 10.1016/s0887-7963(00)80001-2.
Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N. The clinical significance of blood group antibodies. Transfus Med 2002; 12(5): 287-295. doi: 10.1046/ j.1365-3148.2002.00399.x.
Klein H, Anstee DJ. Mollison’s Blood Transfusion in Clinical Medicine. 11th edn. Oxford: Blackwell Science 2005.
Allen FH, Krabbe SM, Corcoran PA. "A new phenotype (McLeod) in the Kell blood-group system". Vox Sanguinis. 1961; 6 (5): 555–60.
Daniels G and members of the ISBT Working Party on Terminology for Red Cell Surface Antigens. Blood group terminology 2004. Vox Sang 2004; 87: 304-316.
Dean L. Blood Groups and Red Cell Antigens [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2005. Chapter 8, The Kell blood group. Available from: https://www.ncbi.nlm.gov/books/NBK2270.
Reesink HW, Engelfriet CP, Schennach H, Gassner C, Wendel S, Fontão-Wendel R, et al. Donors with a rare pheno (geno) type. Vox Sang 2008; 95(3): 236-253. doi: 10.1111/ j.1423-0410.2008.01084.x.
Peyrard T, Pham BN, Le Pennec PY, Rouger P. Les phénotypes érythrocytaires rares: un enjeu de santé publique [The rare blood groups: a public health challenge]. Transfus Clin Biol 2008; 15(3): 109-119. doi: 10.1016/j.tracli.2008.02.001.
Thornton NM, Grimsley SP. Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems. Immunohematology. 2019; 35(3): 95-101. PMID: 31621367.
Yu LC, Twu YC, Chang CY, Lin M. "Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens". The Journal of Biological Chemistry 2001; 276(13): 10247-10252.
Lin M, Wang CL, Chen FS, Ho LH. Fatal hemolytic transfusion reaction due to anti-Ku in a Knull patient. Immunohematol 2003; 19(1): 19-21. PMID: 15373542
Russo DC, Lee S, Reid ME, Redman CM. Point mutations causing the McLeod phenotype. Transfusion. 2002; 42(3): 287-293. doi: 10.1046/j.1537-2995.2002.00049.x.
Mourant AE. The establishment of an international panel of blood donors of rare types. Vox Sang 1965; 10: 129-32. doi: 10.1111/j.1423-0410.1965.tb04330.x.
Anstee D, Levene C, Mallory D, Overbeeke M, Poole J, Reid M, et al. Rare blood. An ISBT Working Party report on rare blood donors. International Society of Blood Transfusion. Vox Sang 1999; 77(1): 58-62. doi: 10.1159/000031075.
Nance S, Scharberg EA, Thornton N, Yahalom V, Sareneva I, Lomas-Francis C. International rare donor panels: a review. Vox Sang 2016; 110 (3): 209-18. doi: 10.1111/ vox.12357.
Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. Second ed. New York: Elsevier Academic Press 2004.
Yu Y, Ma C, Sun X, Guan X, Zhang X, Saldanha J, et al. Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China. Int J Immunogenet 2016; 43(4): 226-235. doi: 10.1111/iji.12277.
Dean L. The Kidd blood group. Blood Groups and Red Cell Antigens. Bethesda, MD: National Center for Biotechnology Information. 2005:1-5. Available at: http://www.ncbi.nlm.nih.gov/books/NBK2272/. Accessed on: February 27, 2015.
Levinson W. Medical microbiology & immunology: examination & board review. New York: Lange Medical Books/McGraw-Hill 2004. ISBN 978-0-07-143199-6.
Owaidah AY, Naffaa NM, Alumran A, Alzahrani F. Phenotype Frequencies of Major Blood Group Systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) Among Blood Donors in the Eastern Region of Saudi Arabia. Journal of Blood Medicine 2020; 11: 59-65. doi: 10.2147/JBM.S236834.
Thakral B, Saluja K, Sharma RR, Marwaha N. Phenotype frequencies of blood groups systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors. Transfus Apher Sci 2010; 43(1): 17-22. doi: 10.1016/j.transci.2010.05.006.
Kobayashi T, Liu D, Ogawa H, Miwa Y, Nagasaka T, Maruyama S, et al. Alternative strategy for overcoming ABO incompatibility. Transplantation 2007; 83(9): 1284-1286. doi: 10.1097/01.tp.0000260634.85690.c4.
Hashemi-Najafabadi S, Vasheghani-Farahani E, Shojaosadati SA, Rasaee MJ, Armstrong JK, Moin M, et al. A method to optimize PEG-coating of red blood cells. Bioconjug Chem 2006; 17(5): 1288-1293. doi: 10.1021/bc060057w.
Kulkarni S, Maru H. Extended phenotyping of blood group antigens: Towards improved transfusion practices. Glob J Transf Med 2020; 5(2): 120-125. doi: 10.4103/GJTM. GJTM_56_20.
Hirani R, Tarafdar S, Mondy P, Powley T, Daly J, Irving DO. Understanding the demand for phenotyped red blood cell units and requests to perform molecular red blood cell typing for Australian patients. Transfus Apher Sci 2021; 60(1): 102968. doi: 10.1016/ j.transci.2020.102968.
Liu Z, Zeng R, Chen Q, Li M, Shi G, Wei P, et al. Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han. Chin Med J (Engl) 2012; 125(6): 1076-1081. PMID: 22613534.
Menegati SFP, Santos TD, Macedo MD, Castilho L. Discrepancies between red cell phenotyping and genotyping in daily immunohematology laboratory practice. Transfus Apher Sci 2020; 59(1): 102585. https://doi.org/10.1016/j.transci.2019.06.020.
Quirino MG, Colli CM, Macedo LC, Ana Maria Sell AM, Laguila Visentainer JE. Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping. Hematol Transfus Cell Ther 2019; 41(1): 44-49. doi: 10.1016/ j.htct.2018.06.006.
